Literature DB >> 23329828

Mucin-type O-glycosylation during development.

Duy T Tran1, Kelly G Ten Hagen.   

Abstract

Mucin-type O-glycosylation is an evolutionarily conserved protein modification present on membrane-bound and secreted proteins. Aberrations in O-glycosylation are responsible for certain human diseases and are associated with disease risk factors. Recent studies have demonstrated essential roles for mucin-type O-glycosylation in protein secretion, stability, processing, and function. Here, we summarize our current understanding of the diverse roles of mucin-type O-glycosylation during eukaryotic development. Appreciating how this conserved modification operates in developmental processes will provide insight into its roles in human disease and disease susceptibilities.

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23329828      PMCID： PMC3591602          DOI： 10.1074/jbc.R112.418558

Source DB:  PubMed          Journal:  J Biol Chem        ISSN： 0021-9258            Impact factor:   5.157


  76 in total

1.  Cloning and expression of a novel, tissue specifically expressed member of the UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase family.

Authors:  K G Ten Hagen; F K Hagen; M M Balys; T M Beres; B Van Wuyckhuyse; L A Tabak
Journal:  J Biol Chem       Date:  1998-10-16       Impact factor: 5.157

Review 2.  Immunoreactive T and Tn epitopes in cancer diagnosis, prognosis, and immunotherapy.

Authors:  G F Springer
Journal:  J Mol Med (Berl)       Date:  1997-08       Impact factor: 4.599

3.  Substrate specificities of three members of the human UDP-N-acetyl-alpha-D-galactosamine:Polypeptide N-acetylgalactosaminyltransferase family, GalNAc-T1, -T2, and -T3.

Authors:  H H Wandall; H Hassan; E Mirgorodskaya; A K Kristensen; P Roepstorff; E P Bennett; P A Nielsen; M A Hollingsworth; J Burchell; J Taylor-Papadimitriou; H Clausen
Journal:  J Biol Chem       Date:  1997-09-19       Impact factor: 5.157

4.  A novel GALNT3 mutation in a pseudoautosomal dominant form of tumoral calcinosis: evidence that the disorder is autosomal recessive.

Authors:  Shoji Ichikawa; Kenneth W Lyles; Michael J Econs
Journal:  J Clin Endocrinol Metab       Date:  2005-02-01       Impact factor: 5.958

5.  Isoform-specific O-glycosylation by murine UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase-T3, in vivo.

Authors:  K Nehrke; F K Hagen; L A Tabak
Journal:  Glycobiology       Date:  1998-04       Impact factor: 4.313

6.  An FGF23 missense mutation causes familial tumoral calcinosis with hyperphosphatemia.

Authors:  Anna Benet-Pagès; Peter Orlik; Tim M Strom; Bettina Lorenz-Depiereux
Journal:  Hum Mol Genet       Date:  2004-12-08       Impact factor: 6.150

7.  Characterization of mucin-type core-1 beta1-3 galactosyltransferase homologous enzymes in Drosophila melanogaster.

Authors:  Reto Müller; Andreas J Hülsmeier; Friedrich Altmann; Kelly Ten Hagen; Michael Tiemeyer; Thierry Hennet
Journal:  FEBS J       Date:  2005-09       Impact factor: 5.542

8.  Characterization of a UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase that displays glycopeptide N-acetylgalactosaminyltransferase activity.

Authors:  K G Ten Hagen; D Tetaert; F K Hagen; C Richet; T M Beres; J Gagnon; M M Balys; B VanWuyckhuyse; G S Bedi; P Degand; L A Tabak
Journal:  J Biol Chem       Date:  1999-09-24       Impact factor: 5.157

9.  Cloning and characterization of a close homologue of human UDP-N-acetyl-alpha-D-galactosamine:Polypeptide N-acetylgalactosaminyltransferase-T3, designated GalNAc-T6. Evidence for genetic but not functional redundancy.

Authors:  E P Bennett; H Hassan; U Mandel; M A Hollingsworth; N Akisawa; Y Ikematsu; G Merkx; A G van Kessel; S Olofsson; H Clausen
Journal:  J Biol Chem       Date:  1999-09-03       Impact factor: 5.157

10.  Core 2 oligosaccharide biosynthesis distinguishes between selectin ligands essential for leukocyte homing and inflammation.

Authors:  L G Ellies; S Tsuboi; B Petryniak; J B Lowe; M Fukuda; J D Marth
Journal:  Immunity       Date:  1998-12       Impact factor: 31.745
View more
  101 in total

1.  Deconstruction of O-glycosylation--GalNAc-T isoforms direct distinct subsets of the O-glycoproteome.

Authors:  Katrine T Schjoldager; Hiren J Joshi; Yun Kong; Christoffer K Goth; Sarah Louise King; Hans H Wandall; Eric P Bennett; Sergey Y Vakhrushev; Henrik Clausen
Journal:  EMBO Rep       Date:  2015-11-13       Impact factor: 8.807

Review 2.  N-glycoprotein macroheterogeneity: biological implications and proteomic characterization.

Authors:  Lucia F Zacchi; Benjamin L Schulz
Journal:  Glycoconj J       Date:  2015-12-05       Impact factor: 2.916

3.  Prediction of O-glycosylation sites based on multi-scale composition of amino acids and feature selection.

Authors:  Yuan Chen; Wei Zhou; Haiyan Wang; Zheming Yuan
Journal:  Med Biol Eng Comput       Date:  2015-03-10       Impact factor: 2.602

Review 4.  Pathobiological implications of mucin glycans in cancer: Sweet poison and novel targets.

Authors:  Seema Chugh; Vinayaga S Gnanapragassam; Maneesh Jain; Satyanarayana Rachagani; Moorthy P Ponnusamy; Surinder K Batra
Journal:  Biochim Biophys Acta       Date:  2015-08-28

5.  Precision mapping of the human O-GalNAc glycoproteome through SimpleCell technology.

Authors:  Catharina Steentoft; Sergey Y Vakhrushev; Hiren J Joshi; Yun Kong; Malene B Vester-Christensen; Katrine T-B G Schjoldager; Kirstine Lavrsen; Sally Dabelsteen; Nis B Pedersen; Lara Marcos-Silva; Ramneek Gupta; Eric Paul Bennett; Ulla Mandel; Søren Brunak; Hans H Wandall; Steven B Levery; Henrik Clausen
Journal:  EMBO J       Date:  2013-04-12       Impact factor: 11.598

6.  Tenectin recruits integrin to stabilize bouton architecture and regulate vesicle release at the Drosophila neuromuscular junction.

Authors:  Qi Wang; Tae Hee Han; Peter Nguyen; Michal Jarnik; Mihaela Serpe
Journal:  Elife       Date:  2018-06-14       Impact factor: 8.140

Review 7.  Genomic approaches in the search for molecular biomarkers in chronic kidney disease.

Authors:  M Cañadas-Garre; K Anderson; J McGoldrick; A P Maxwell; A J McKnight
Journal:  J Transl Med       Date:  2018-10-25       Impact factor: 5.531

Review 8.  Chemoenzymatic Methods for the Synthesis of Glycoproteins.

Authors:  Chao Li; Lai-Xi Wang
Journal:  Chem Rev       Date:  2018-08-24       Impact factor: 60.622

9.  Polypeptide N-Acetylgalactosaminyltransferase 13 Contributes to Neurogenesis via Stabilizing the Mucin-type O-Glycoprotein Podoplanin.

Authors:  Yingjiao Xu; Wenjie Pang; Jishun Lu; Aidong Shan; Yan Zhang
Journal:  J Biol Chem       Date:  2016-09-14       Impact factor: 5.157

10.  Mucin-type O-glycosylation is controlled by short- and long-range glycopeptide substrate recognition that varies among members of the polypeptide GalNAc transferase family.

Authors:  Leslie Revoredo; Shengjun Wang; Eric Paul Bennett; Henrik Clausen; Kelley W Moremen; Donald L Jarvis; Kelly G Ten Hagen; Lawrence A Tabak; Thomas A Gerken
Journal:  Glycobiology       Date:  2015-11-26       Impact factor: 4.313
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.